Muhammad Ijaz, Mohsin Khurshid, Jingsi Gu, Ikram Hasan, Shubham Roy, Zia Ullah, Simin Liang, Jing Cheng, Yinghe Zhang, Chao Mi, Bing Guo
Cancer, the leading global cause of mortality, poses a formidable challenge for treatment. The effectiveness of cancer therapies, ranging from chemotherapy to immunotherapy, relies on the precise delivery of therapeutic agents to tumor tissues. Nanobiohybrids, resulting from the fusion of bacteria with nanomaterials, constitute a promising delivery system. Nanobiohybrids offer several advantages, including the ability to target tumors, genetic engineering capabilities, programmed product creation, and the potential for multimodal treatment...
April 15, 2024: Nanoscale